Literature DB >> 6034369

The metabolism of desferrioxamine B and ferrioxamine B.

H G Meyer-Brunot, H Keberle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6034369     DOI: 10.1016/0006-2952(67)90100-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

Review 1.  Deferoxamine (desferrioxamine). New toxicities for an old drug.

Authors:  Y Bentur; M McGuigan; G Koren
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

2.  Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis.

Authors:  P Allain; Y Mauras; D Chaleil; P Simon; K S Ang; G Cam; L Le Mignon; M Simon
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

3.  Quantitative measurement of iron stores with diethylenetriamine penta-acetic acid.

Authors:  M Barry; G Cartei; S Sherlock
Journal:  Gut       Date:  1970-11       Impact factor: 23.059

4.  Clinically achievable plasma deferoxamine concentrations are therapeutic in a rat model of Pneumocystis carinii pneumonia.

Authors:  S Merali; K Chin; L Del Angel; R W Grady; M Armstrong; A B Clarkson
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

5.  Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamine.

Authors:  S Merali; K Chin; R W Grady; L Weissberger; A B Clarkson
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

6.  Iron: a target for the management of Kaposi's sarcoma?

Authors:  Thierry Simonart
Journal:  BMC Cancer       Date:  2004-01-15       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.